• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Letter by Monzo and Melenovsky Regarding Article, "Metabolomic Profiling of the Effects of Dapagliflozin in Heart Failure With Reduced Ejection Fraction: DEFINE-HF".

作者信息

Monzo Luca, Melenovsky Vojtech

机构信息

Institute for Clinical and Experimental Medicine, Prague, Czech Republic (L.M., V.M.).

Sapienza University, Rome, Italy (L.M.).

出版信息

Circulation. 2023 Mar 14;147(11):920-921. doi: 10.1161/CIRCULATIONAHA.122.061155. Epub 2023 Mar 13.

DOI:10.1161/CIRCULATIONAHA.122.061155
PMID:36913496
Abstract
摘要

相似文献

1
Letter by Monzo and Melenovsky Regarding Article, "Metabolomic Profiling of the Effects of Dapagliflozin in Heart Failure With Reduced Ejection Fraction: DEFINE-HF".蒙佐和梅莱诺夫斯基就文章《达格列净对射血分数降低的心力衰竭的影响的代谢组学分析：DEFINE-HF》所写的信函
Circulation. 2023 Mar 14;147(11):920-921. doi: 10.1161/CIRCULATIONAHA.122.061155. Epub 2023 Mar 13.
2
Response by Selvaraj et al to Letter Regarding Article, "Metabolomic Profiling of the Effects of Dapagliflozin in Heart Failure With Reduced Ejection Fraction: DEFINE-HF".塞尔瓦拉杰等人对关于文章《达格列净对射血分数降低的心力衰竭的影响的代谢组学分析：DEFINE-HF》的信件的回应
Circulation. 2023 Mar 14;147(11):922-923. doi: 10.1161/CIRCULATIONAHA.122.063395. Epub 2023 Mar 13.
3
Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction: The DEFINE-HF Trial.达格列净对射血分数降低的心力衰竭患者生物标志物、症状和功能状态的影响：DEFINE-HF 试验。
Circulation. 2019 Oct 29;140(18):1463-1476. doi: 10.1161/CIRCULATIONAHA.119.042929. Epub 2019 Sep 16.
4
Efficacy and safety of sodium-glucose co-transporter 2 inhibition according to left ventricular ejection fraction in DAPA-HF.达格列净对射血分数降低的心力衰竭患者的疗效和安全性(DAPA-HF)。
Eur J Heart Fail. 2020 Jul;22(7):1247-1258. doi: 10.1002/ejhf.1867. Epub 2020 Jun 15.
5
Positive effect of dapagliflozin on left ventricular longitudinal function for type 2 diabetic mellitus patients with chronic heart failure.达格列净对合并慢性心力衰竭的 2 型糖尿病患者左心室纵向功能的积极影响。
Cardiovasc Diabetol. 2020 Jan 7;19(1):6. doi: 10.1186/s12933-019-0985-z.
6
The DAPA-HF trial marks the beginning of a new era in the treatment of heart failure with reduced ejection fraction.DAPA-HF试验标志着射血分数降低的心力衰竭治疗新时代的开始。
Cardiovasc Res. 2020 Jan 1;116(1):e8-e10. doi: 10.1093/cvr/cvz328.
7
Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus.达格列净对 2 型糖尿病心力衰竭和死亡的影响。
Circulation. 2019 May 28;139(22):2528-2536. doi: 10.1161/CIRCULATIONAHA.119.040130. Epub 2019 Mar 18.
8
Efficacy and Safety of Dapagliflozin in Heart Failure With Reduced Ejection Fraction According to N-Terminal Pro-B-Type Natriuretic Peptide: Insights From the DAPA-HF Trial.达格列净在射血分数降低的心力衰竭中的疗效和安全性：来自 DAPA-HF 试验的 NT-proBNP 见解。
Circ Heart Fail. 2021 Dec;14(12):e008837. doi: 10.1161/CIRCHEARTFAILURE.121.008837. Epub 2021 Nov 22.
9
Impact of Dapagliflozin on Mortality in Patients With Heart Failure and Reduced Ejection Fraction: A Meta-analysis.达格列净对射血分数降低的心力衰竭患者死亡率的影响：一项荟萃分析。
Am J Ther. 2022;29(5):e578-e579. doi: 10.1097/MJT.0000000000001354. Epub 2021 May 28.
10
Effects of Dapagliflozin on Symptoms, Function, and Quality of Life in Patients With Heart Failure and Reduced Ejection Fraction: Results From the DAPA-HF Trial.达格列净对射血分数降低的心力衰竭患者症状、功能和生活质量的影响：来自 DAPA-HF 试验的结果。
Circulation. 2020 Jan 14;141(2):90-99. doi: 10.1161/CIRCULATIONAHA.119.044138. Epub 2019 Nov 17.